217 related articles for article (PubMed ID: 24252211)
1. MCP-1/CCR2 signaling-mediated astrocytosis is accelerated in a transgenic mouse model of SOD1-mutated familial ALS.
Kawaguchi-Niida M; Yamamoto T; Kato Y; Inose Y; Shibata N
Acta Neuropathol Commun; 2013 Jun; 1():21. PubMed ID: 24252211
[TBL] [Abstract][Full Text] [Related]
2. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS.
Kadoyama K; Funakoshi H; Ohya W; Nakamura T
Neurosci Res; 2007 Dec; 59(4):446-56. PubMed ID: 17935811
[TBL] [Abstract][Full Text] [Related]
4. Protein-bound crotonaldehyde accumulates in the spinal cord of superoxide dismutase-1 mutation-associated familial amyotrophic lateral sclerosis and its transgenic mouse model.
Shibata N; Kawaguchi M; Uchida K; Kakita A; Takahashi H; Nakano R; Fujimura H; Sakoda S; Ihara Y; Nobukuni K; Takehisa Y; Kuroda S; Kokubo Y; Kuzuhara S; Honma T; Mochizuki Y; Mizutani T; Yamada S; Toi S; Sasaki S; Iwata M; Hirano A; Yamamoto T; Kato Y; Sawada T; Kobayashi M
Neuropathology; 2007 Feb; 27(1):49-61. PubMed ID: 17319283
[TBL] [Abstract][Full Text] [Related]
5. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
6. Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS.
Barbeito AG; Martinez-Palma L; Vargas MR; Pehar M; MaƱay N; Beckman JS; Barbeito L; Cassina P
Neurobiol Dis; 2010 Mar; 37(3):574-80. PubMed ID: 19914377
[TBL] [Abstract][Full Text] [Related]
7. Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis.
Shibata N; Yamamoto T; Hiroi A; Omi Y; Kato Y; Kobayashi M
Neuropathology; 2010 Aug; 30(4):353-60. PubMed ID: 19925559
[TBL] [Abstract][Full Text] [Related]
8. CCR2 is localized in microglia and neurons, as well as infiltrating monocytes, in the lumbar spinal cord of ALS mice.
Komiya H; Takeuchi H; Ogawa Y; Hatooka Y; Takahashi K; Katsumoto A; Kubota S; Nakamura H; Kunii M; Tada M; Doi H; Tanaka F
Mol Brain; 2020 Apr; 13(1):64. PubMed ID: 32349774
[TBL] [Abstract][Full Text] [Related]
9. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
10. Monocyte Chemoattractant Protein-1 upregulates GABA-induced current: evidence of modified GABAA subunit composition in cortical neurons from the G93A mouse model of Amyotrophic Lateral Sclerosis.
Caioli S; Pieri M; Antonini A; Guglielmotti A; Severini C; Zona C
Neuropharmacology; 2013 Oct; 73():247-60. PubMed ID: 23752092
[TBL] [Abstract][Full Text] [Related]
11. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
13. H63D HFE genotype accelerates disease progression in animal models of amyotrophic lateral sclerosis.
Nandar W; Neely EB; Simmons Z; Connor JR
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2413-26. PubMed ID: 25283820
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients.
Johann S; Heitzer M; Kanagaratnam M; Goswami A; Rizo T; Weis J; Troost D; Beyer C
Glia; 2015 Dec; 63(12):2260-73. PubMed ID: 26200799
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
16. Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1).
Harlan BA; Pehar M; Sharma DR; Beeson G; Beeson CC; Vargas MR
J Biol Chem; 2016 May; 291(20):10836-46. PubMed ID: 27002158
[TBL] [Abstract][Full Text] [Related]
17. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang Q; Martin LJ
J Neurosci; 2011 Feb; 31(8):2815-27. PubMed ID: 21414903
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis.
Acevedo-Arozena A; Kalmar B; Essa S; Ricketts T; Joyce P; Kent R; Rowe C; Parker A; Gray A; Hafezparast M; Thorpe JR; Greensmith L; Fisher EM
Dis Model Mech; 2011 Sep; 4(5):686-700. PubMed ID: 21540242
[TBL] [Abstract][Full Text] [Related]
19. Clearance of peripheral nerve misfolded mutant protein by infiltrated macrophages correlates with motor neuron disease progression.
Shiraishi W; Yamasaki R; Hashimoto Y; Ko S; Kobayakawa Y; Isobe N; Matsushita T; Kira JI
Sci Rep; 2021 Aug; 11(1):16438. PubMed ID: 34385589
[TBL] [Abstract][Full Text] [Related]
20. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]